Haemonetics: Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

In This Article: BOSTON , Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 at 2:50 p.m. ET . The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://wsw.com/webcast/rj131/hae/1437678 . A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website. ABOUT HAEMONETICS Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com . Investor Contacts: Olga Guyette , Vice President-Investor Relations & Treasury (781) 356-9763 olga.guyette@haemonetics.com David Trenk , Manager-Investor Relations (203) 733-4987 david.trenk@haemonetics.com Media Contact: Josh Gitelson , Sr. Director-Global Communications (781) 356-9776 josh.gitelson@haemonetics.com Cision